PREVACID CAPSULE 30 mg

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

LANSOPRAZOLE

Available from:

TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.

ATC code:

A02BC03

Dosage:

30 mg

Pharmaceutical form:

CAPSULE

Composition:

LANSOPRAZOLE 30 mg

Administration route:

ORAL

Prescription type:

Prescription Only

Manufactured by:

TAKEDA PHARMACEUTICAL CO LTD

Authorization status:

ACTIVE

Authorization date:

1995-07-29

Patient Information leaflet

Package insert for Singapore

PREVACID

 CAPSULES 
(Lansoprazole Capsules) 

PREVACID

 Capsule is a preparation
of lanzoprazole, a proton pump inhibitor. 
PREVACID

 Capsule inhibits the gastric acid secretion
strongly and sustainedly by suppressing 
the activity of (H-
+
/K-
+
)-ATPase which is locally existed in the parietal cells of gastric
mucosa and 
plays an important role as a proton pump. 
Clinically, PREVACID

 Capsule attains a rapid and high
healing ratio against gastric ulcer and 
duodenal ulcer, and the usefulness of the drug has been proved. It has also
been proved to be a 
useful drug for the treatment of stomal ulcer, reflux esophagitis and Zollinger- Ellison syndrome. 

COMPOSITION 
PREVACID

 Capsule is a white hard capsule preparation containing 30 mg of lansoprazole in
each 
capsule. 

INDICATION 
- Gastric
ulcer, duodenal ulcer, stomal ulcer, reflux esophagitis and Zollinger-Ellison
syndrome. 
-   Maintenance treatment of reflux esophagitis 
-   Peptic lesion unresponsive to H
2
 receptor antagonist 
- Eradication
of H. pylori from the upper gastrointestinal tract in patients with peptic ulcer (duodenal 
or benign gastric ulcer) when used in combination
with appropriate antibiotics. 
- Healing and prevention of NSAID-induced ulcers. 
- Treatment of NSAID-associated benign ulcers, duodenal ulcers, relief of
symptoms in patients 
requiring continued NSAID treatment, and risk reduction
of NSAID-associated gastric ulcer. 

DOSAGE AND ADMINISTRATION 
Usually for adults, administer one
capsule (30 mg of lansoprazole) orally once a day. 
In duodenal ulcer, 30 mg once daily for 4 weeks.  In gastric
ulcer and stomal ulcer, 30 mg once 
daily for 8 weeks.  In
reflux esophagitis, 30 mg once daily for 4-8 weeks. Patients can
be continued 
at a maintenance dosag

Summary of Product characteristics

PREVACID
 CAPSULES
(Lansoprazole Capsules)
PREVACID

Capsule is a preparation of lanzoprazole, a proton pump inhibitor.
PREVACID

Capsule inhibits the gastric acid secretion strongly and sustainedly
by suppressing
the activity of (H-
+
/K-
+
)-ATPase which is locally existed in the parietal cells of gastric
mucosa and
plays an important role as a proton pump.
Clinically, PREVACID

Capsule attains a rapid and high healing ratio against gastric ulcer
and
duodenal ulcer, and the usefulness of the drug has been proved. It has
also been proved to be a
useful drug for the treatment of stomal ulcer, reflux esophagitis and
Zollinger- Ellison syndrome.
COMPOSITION
PREVACID

Capsule is a white hard capsule preparation containing 30 mg of
lansoprazole in each
capsule.
INDICATION
- Gastric ulcer, duodenal ulcer, stomal ulcer, reflux esophagitis and
Zollinger-Ellison syndrome.
- Maintenance treatment of reflux esophagitis
- Peptic lesion unresponsive to H
2
receptor antagonist
-
Eradication of H. pylori from the upper gastrointestinal tract in
patients with peptic ulcer (duodenal
or benign gastric ulcer) when used in combination with appropriate
antibiotics.
-
Healing and prevention of NSAID-induced ulcers.
-
Treatment of NSAID-associated benign ulcers, duodenal ulcers, relief
of symptoms in patients
requiring continued NSAID treatment, and risk reduction of
NSAID-associated gastric ulcer.
DOSAGE AND ADMINISTRATION
Usually for adults, administer one capsule (30 mg of lansoprazole)
orally once a day.
In duodenal ulcer, 30 mg once daily for 4 weeks. In gastric ulcer and
stomal ulcer, 30 mg once
daily for 8 weeks. In reflux esophagitis, 30 mg once daily for 4-8
weeks. Patients can be continued
at a maintenance dosage of 15mg once daily. In individual cases a
dosage of 30mg once daily may
be necessary. In Zollinger-Ellison syndrome, the dosage should be
adjusted according to the
patient’s signs and symptoms.
Eradication of H.pylori : The following combinations have been shown
to be effective over 7 days.
Prevacid